What is CytomX Therapeutics's debt-to-assets?

CytomX Therapeutics (CTMX) reported debt-to-assets of 0× in Q1 2026.

How has CytomX Therapeutics's debt-to-assets changed year-over-year?

CytomX Therapeutics's debt-to-assets decreased by 90.4% year-over-year, from 0.1× to 0×.

What is the long-term trend for CytomX Therapeutics's debt-to-assets?

Over 5 years (2020 to 2025), CytomX Therapeutics's debt-to-assets has grown at a -16.6% compound annual growth rate (CAGR), from 0.1× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

CytomX Therapeutics CTMX Debt-to-assets

Debt-to-assets at other companies

PfizerPFE

0.3×0.0×

AmgenAMGN

0.6×0.0×

Janux TherapeuticsJANX

0×0.0×

Allogene TherapeuticsALLO

0.2×0.0×

Vor BiopharmaVOR

0×-0.3×

Design Therapeutics, Inc.DSGN

0×0.0×

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Calculated from CytomX Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's debt-to-assets?: CytomX Therapeutics (CTMX) reported debt-to-assets of 0× in Q1 2026.
How has CytomX Therapeutics's debt-to-assets changed year-over-year?: CytomX Therapeutics's debt-to-assets decreased by 90.4% year-over-year, from 0.1× to 0×.
What is the long-term trend for CytomX Therapeutics's debt-to-assets?: Over 5 years (2020 to 2025), CytomX Therapeutics's debt-to-assets has grown at a -16.6% compound annual growth rate (CAGR), from 0.1× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.